About: Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 2004

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2004 (uk) im Juli 2004 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 2004 (ast) scientific article published on 01 July 2004 (en)
publication date	wds:Q80332621-5D685415-35C8-4F90-8799-BB33A94BAC06
publication date	2004-07-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q80332621-5418401B-3D1F-4B0C-81D8-760D69EB990D wds:Q80332621-8CBFF352-6F30-49DA-944A-B6E5F033F36F
author name string	American College of Chest Physicians Lewis J Rubin
rdfs:label	Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines (en) Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines (nl)
skos:prefLabel	Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines (en) Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines (nl)
name	Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines (en) Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines (nl)
title	wds:Q80332621-1282D4E7-1614-4EB2-9E4D-109D75159FEB
title	Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines (en)
page(s)	wds:Q80332621-320ECBA4-2FD7-4137-B341-A97CB879C0F4
page(s)	7S-10S
instance of	wds:Q80332621-E764FA1F-BC62-4440-950C-EC7D4FB8E1C6
instance of	scholarly article
main subject	wds:Q80332621-04018EC2-32DE-4B16-A6BE-F91E1AEBF3FD
main subject	arterial hypertension
PubMed ID	wds:Q80332621-3CDAE176-CDBC-43E5-9167-2A056F6488C5
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15249491
PubMed ID	15249491
published in	wds:Q80332621-AE9BF384-C192-453A-8AAE-FF7E48D090C3
published in	Chest
issue	wds:Q80332621-8FFCB239-96F6-4BB1-A6CB-4E2997C5B620
volume	wds:Q80332621-84DA5CAF-8D99-41D0-B01B-F3AEBB2BB488
issue	1 Suppl
volume	126
DOI	wds:Q80332621-28B8F088-A507-443B-8A7F-D691B9099E6A
DOI	http://dx.doi.org/10.1378/CHEST.126.1_SUPPL.7S
DOI	10.1378/CHEST.126.1_SUPPL.7S
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80332621
is cites work of	Inhaled iloprost for the control of pulmonary hypertension Transition from intravenous epoprostenol to oral or subcutaneous therapy in pulmonary arterial hypertension: a retrospective case series and systematic review Simvastatin ameliorates established pulmonary hypertension through a heme oxygenase-1 dependent pathway in rats Sildenafil: a review of its use in pulmonary arterial hypertension Cost-utility of treatments for pulmonary arterial hypertension: a Markov state-transition decision analysis model Hemodynamic profile of portopulmonary hypertension Response to bosentan in children with pulmonary hypertension The combination of exercise and respiratory training improves respiratory muscle function in pulmonary hypertension. Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients Migraine with aura following atrial septostomy for pulmonary arterial hypertension Vasodilator testing with nitric oxide and/or oxygen in pediatric pulmonary hypertension Pulmonary hypertension and chronic cor pulmonale in COPD Chronic thromboembolic pulmonary hypertension (CTEPH). The Implantable Pediatric Artificial Lung: Interim Report on the Development of an End-Stage Lung Failure Model Diagnostic dilemma in a child with congenital heart disease on sildenafil [Clinical efficacy of sildenafil in patients with pulmonary hypertension in functional class II or III] Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension Pulmonary hypertension caused by sarcoidosis Drug treatment of pulmonary arterial hypertension: current and future agents New mechanisms of pulmonary arterial hypertension: role of Ca²⁺ signaling. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort Genetics of systemic sclerosis-associated pulmonary arterial hypertension: recent progress and current concepts Pulmonary Arterial Hypertension in Adult-Onset Still's Disease: Rapid Response to Anakinra. Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension Exercise training in patients with pulmonary arterial hypertension: a case report Human immunodeficiency virus and pulmonary arterial hypertension Benefits of chronic blood transfusion in hemoglobin E/β thalassemia with pulmonary arterial hypertension Thyrotoxicosis presenting as exertional dyspnea and pulmonary hypertension: Case report and review of literature Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension Adventitial alterations are the main features in pulmonary artery remodeling due to long-term chronic intermittent hypobaric hypoxia in rats Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire Ventilatory efficiency slope correlates with functional capacity, outcomes, and disease severity in pediatric patients with pulmonary hypertension Pulmonary hypertension in chronic obstructive pulmonary disease and emphysema patients: prevalence, therapeutic options and pulmonary circulatory effects of lung volume reduction surgery Exercise-based rehabilitation programmes for pulmonary hypertension Breaking Down the Barriers: Why the Delay in Referral for Pulmonary Arterial Hypertension? Outcomes of Pulmonary Arterial Hypertension are Improved in a Specialty Care Center Circulating miRNAs in Pediatric Pulmonary Hypertension Show Promise as Biomarkers of Vascular Function Cavitating lung lesions in chronic thromboembolic pulmonary hypertension Prevalence of echocardiographic criteria for the diagnosis of pulmonary hypertension in patients with Graves' disease: before and after antithyroid treatment Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease [Image-guided minimally invasive treatment of pulmonary arterial hypertension due to embolic disease] [Pulmonary diseases and heart function] Long-Term Intermittent Work at High Altitude: Right Heart Functional and Morphological Status and Associated Cardiometabolic Factors. Directing therapy in pulmonary arterial hypertension using a target 6 min walk distance Recent trends in pulmonary arterial hypertension Functional mutations in 5'UTR of the BMPR2 gene identified in Chinese families with pulmonary arterial hypertension Effect of acetylsalicylic acid on thalassemia with pulmonary arterial hypertension Provider recognition and response to echocardiographic findings indicating pulmonary hypertension in the Veterans affairs medical center population Pulmonary arterial hypertension Pulmonary arterial hypertension in children: diagnosis using ratio of main pulmonary artery to ascending aorta diameter as determined by multi-detector computed tomography. Identification of myocardial damage in systemic sclerosis: a nuclear cardiology approach. Comprehensive Exercise Capacity and Quality of Life Assessments Predict Mortality in Patients with Pulmonary Arterial Hypertension Abnormal pulmonary artery systolic pressure response after exercise in systemic sclerosis patients: A PRISMA-compliant meta-analysis Are endothelin-receptor antagonists the preferred treatment for PAH associated with scleroderma? Integrated care and optimal management of pulmonary arterial hypertension [Lung diseases - pulmonary hypertension] Management of acute subdural hematoma in a patient with portopulmonary hypertension on prostanoid therapy Therapie der pulmonalarteriellen Hypertonie
is cites work of	wds:Q33154584-401D893B-C0ED-43DC-90C1-78166402E104 wds:Q37079127-975A7A38-83F9-4323-B633-0723F1CE5026 wds:Q34663285-57298FE0-63E1-4C6F-8834-6208F78983D5

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software